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A gram-negative, facultatively anaerobic rod, Escherichia coli was named for Theodor Escherich, a German-Austrian pediatrician. Escherich isolated a variety 
of bacteria from infant fecal samples by using his own anaerobic culture methods and 
Hans Christian Gram’s new staining technique. Escherich originally named the common 
colon bacillus Bacterium coli commune. Castellani and Chalmers proposed the name 
E. coli in 1919, but it was not officially recognized until 1958.
Escherichia coli [eshʺə-rikʹe-ə coʹlī]
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